The Brief Introduction Of Wanbang Biopharmaceuticalswanbang Biopharmaceuticalsbrief Inwanbang Biopharma Is The Core Member Of Shanghai Fosun Pharmaceuticalgroupco Ltdbrief Infosun Pharma Stock Code600196 Sh02196 Hk Wanbang Biopharma Was Established In 1981 With The Former Name Of Xuzhou Biochemical Pharmaceutical Factoryreformed To Xuzhou Wanbang Biochemistry Pharmaceuticals Ltd In 1998Named As Jiangsu Wanbang Biopharmaceuticals Co Ltd In 2001Joined In Fosun Pharma In 2004And Upgraded To Wanbang Biopharma Group In 2017 Wanbang Biopharma Has Domestic First Class Prokaryotic And Eukaryotic Gene Cell Engineering Pharmaceutical Research And Production Sitethrough Equity Participationwanbang Established A Small Molecule Innovative Drug Research And Development Laboratory In San Franciscunited Statesso It Also Is In The Leading Position Of High Difficulty Generics In The Industrywanbang Invests About 10Of The Sales Revenue For New Product Research And Developmentwanbang S R&D Team Has Over 200 Full Time Staffamong Which Over 50Are Highly Qualified Personnel Such As Master S Degree And Doctoral Degreeeach Yearaveragelythey Apply For More Than Twenty National Patents And Several New Products Are Launched Into Market Wanbang Biopharma Holding Manages 17 Subsidiariesplease Find The List In The Annexand Has Established 10 Manufacturing Sites Throughout Chinait Has The Qualifications Of Pharmaceutical Products Productionwholesalechain Drugstoresinternet Sales And Other Related Business Qualificationwanbang Biopharma Recently Invested Nearly 600 Million Rmb To Design And Built A Cgmp Standard Biological Product Workshop And Fpf Joint Workshop According To European And American Pharmaceutical Management Conceptswhose Key Production And Analysis Equipment Are Top Leading Of The World
China
Germany
